epratuzumab

Related by string. Epratuzumab * * candidate epratuzumab . evaluating epratuzumab *

Related by context. Frequent words. (Click for all words.) 62 Marqibo 61 ofatumumab 61 IMGN# 61 HGS ETR1 61 Rituximab 60 TREANDA 59 MGCD# [001] 59 AP# [003] 59 ISIS # 59 FOLOTYN 59 picoplatin 59 eculizumab 59 LymphoStat B 59 blinatumomab 59 perifosine 59 ASA# 59 MDV# 59 lupus nephritis 58 Genasense 58 Perifosine 58 VIDAZA 58 INCB# [002] 58 Phase 2a trial 58 XL# [003] 58 telbivudine 58 AEZS 58 ADVEXIN 58 Actemra 58 tamibarotene 57 Riquent 57 Rhucin 57 HspE7 57 ONCONASE 57 daclizumab 57 panitumumab 57 pralatrexate 57 chronic lymphocytic leukemia CLL 57 BiovaxID 57 vilazodone 57 Defibrotide 57 hematological malignancies 57 infliximab 57 pegloticase 57 dasatinib 57 TroVax 57 Cimzia ® 56 rituximab 56 Locteron 56 clofarabine 56 ambrisentan 56 NGX# 56 voclosporin 56 Atiprimod 56 AZD# 56 golimumab 56 Dacogen 56 JANUVIA 56 Homspera 56 humanized monoclonal antibody 56 adalimumab 56 tesetaxel 56 mipomersen 56 cetrorelix 56 PLX# 56 chronic myeloid leukemia CML 55 Zerenex 55 dimebon 55 bevirimat 55 BCR ABL 55 Azixa 55 Phase IIa trial 55 asenapine 55 T DM1 55 REVLIMID 55 oritavancin 55 Phase 2a 55 Vidaza 55 GATTEX 55 hormone refractory prostate cancer 55 antitumor 55 linaclotide 55 Preclinical studies 55 ZYBRESTAT 55 ALN RSV# 55 ustekinumab 55 belimumab 55 vandetanib 55 DAVANAT R 55 Phase Ib 55 chemotherapeutic agent 55 maraviroc 54 BENLYSTA 54 mAb 54 iloperidone 54 HRPC 54 Clolar 54 ZEVALIN 54 antitumor activity 54 satraplatin 54 Phase IIa 54 ALN VSP

Back to home page